SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043968
Filing Date
2021-08-12
Accepted
2021-08-12 16:09:48
Documents
62
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q trvi-10q_20210630.htm   iXBRL 10-Q 2465568
2 EX-10.5 trvi-ex105_94.htm EX-10.5 27660
3 EX-10.6 trvi-ex106_190.htm EX-10.6 21685
4 EX-31.1 trvi-ex311_7.htm EX-31.1 14042
5 EX-32.1 trvi-ex321_6.htm EX-32.1 10383
6 GRAPHIC gpmwnravwaiv000001.jpg GRAPHIC 40168
  Complete submission text file 0001564590-21-043968.txt   7522704

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA trvi-20210630.xsd EX-101.SCH 47428
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE trvi-20210630_cal.xml EX-101.CAL 42683
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE trvi-20210630_def.xml EX-101.DEF 138875
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE trvi-20210630_lab.xml EX-101.LAB 363427
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trvi-20210630_pre.xml EX-101.PRE 274565
12 EXTRACTED XBRL INSTANCE DOCUMENT trvi-10q_20210630_htm.xml XML 1222399
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38886 | Film No.: 211167610
SIC: 2834 Pharmaceutical Preparations